Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06729866

EGM Guided PFA for PerAF

Electrogram Guided Pulse Field Ablation for Persistent Atrial Fibrillation

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
58 (estimated)
Sponsor
Xu Liu · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pulse field ablation (PFA) has shown safety and efficacy in paroxysmal atrial fibrillation (AF), while the application in persistent atrial fibrillation (PerAF) is still under investigation. The investigators' previous randomized controlled trial showed favorable outcomes with electrogram (EGM) guided radiofrequency ablation in PerAF. However, EGM-guided PFA has not yet been reported.

Detailed description

Multiple studies have confirmed that pulse field ablation (PFA) demonstrates superior safety and efficacy in pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF). However, the application of PFA in persistent atrial fibrillation (PerAF) remains in the exploratory stages. The efficacy and safety of PFA across various ablation strategies require a comprehensive evaluation. Notably, electrogram (EGM) guided PFA ablation for persistent atrial fibrillation has not yet been reported in the literature. In the investigators' previous study on radiofrequency ablation for PerAF, the investigators observed that EGM guided ablation yielded a high success rate. Furthermore, the investigators' recent research has confirmed that intraoperative termination of atrial fibrillation using EGM guided ablation is associated with favorable long-term outcomes in patients with PerAF. The investigators aim to explore the preliminary application of EGM guided pulse field ablation (PFA) in persistent atrial fibrillation.

Conditions

Interventions

TypeNameDescription
PROCEDUREelectrogram guided pulse field ablationIn persistent atrial fibrillation patients, traget electrogram was mapped firstly , pulse field ablation of pulmonary veins, posterior wall of left atrium and target electrogram was ablated, until the atrial fibrillation converted to sinus rythm or stable atrial tachycardia. The mapping and ablation procedure was repeated until AF terminated or no target electrogram was found.

Timeline

Start date
2024-09-20
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2024-12-11
Last updated
2025-06-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06729866. Inclusion in this directory is not an endorsement.